Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy

scientific article published on 13 June 2006

Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/HMG/DDL148
P698PubMed publication ID16772330

P50authorAlbert R. La SpadaQ67390362
P2093author name stringBryce L Sopher
Stephen R Plymate
Vincent Damian
Gregory S Fraley
Francisco Zapata
Lillie B Woodke
Patrick S Thomas
P433issue14
P921main subjectmuscular atrophyQ2844600
P304page(s)2225-2238
P577publication date2006-06-13
P1433published inHuman Molecular GeneticsQ2720965
P1476titleLoss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy
P478volume15

Reverse relations

cites work (P2860)
Q41845006A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia.
Q34407813ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice.
Q34766996Absence of disturbed axonal transport in spinal and bulbar muscular atrophy
Q89031532Activity-Based Physical Rehabilitation with Adjuvant Testosterone to Promote Neuromuscular Recovery after Spinal Cord Injury
Q26850843Androgen insensitivity syndrome
Q33904073Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy
Q30489907Androgen regulation of axon growth and neurite extension in motoneurons
Q39270998Androgenic mechanisms of sexual differentiation of the nervous system and behavior
Q37435253B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy
Q64079981Chronic Microglial Activation in the GFAP-IL6 Mouse Contributes to Age-Dependent Cerebellar Volume Loss and Impairment in Motor Function
Q28285156Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy
Q37183952Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy
Q89146104Deregulation of RNA Metabolism in Microsatellite Expansion Diseases
Q33507519Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype.
Q90167516Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice
Q33636403Disruption of nongenomic testosterone signaling in a model of spinal and bulbar muscular atrophy
Q48196782Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy.
Q33546654Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis
Q33784026Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy
Q35597468Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua
Q38599448Innervation and neuromuscular control in ageing skeletal muscle
Q35141431Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo
Q33801655Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans.
Q36844932Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.
Q33707651Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy
Q64077201Mouse models and strain-dependency of Chédiak-Higashi syndrome-associated neurologic dysfunction
Q26853025Mouse models of polyglutamine diseases: review and data table. Part I
Q33860974Muscle matters in Kennedy's disease
Q30423500Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular Atrophy
Q36081124Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy
Q37899974Neurotoxic effects of androgens in spinal and bulbar muscular atrophy.
Q38082664New routes to therapy for spinal and bulbar muscular atrophy.
Q37162803Non-Cell-Autonomous Regulation of Retrograde Motoneuronal Axonal Transport in an SBMA Mouse Model
Q28272543Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1
Q28593098Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis
Q27007098Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy
Q34138396Perspectives of Kennedy's disease
Q34270135Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA.
Q30498024Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy
Q34672035Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing
Q37253288The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis
Q27342852Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy

Search more.